Company Filing History:
5 out of 639 
1 out of 832,891 Years Active: 2002-2017
Title: Christopher Cotter: Innovator in Nucleic Acid Amplification Technology
Introduction
Christopher Cotter is a notable inventor based in Charlestown, MA (US). He has made significant contributions to the field of nucleic acid amplification, holding a total of 6 patents. His work focuses on developing innovative instruments that enhance the efficiency and effectiveness of diagnostic testing.
Latest Patents
One of Cotter's latest patents is the "Nucleic acid amplification reaction station for disposable test devices." This instrument is designed to conduct nucleic acid amplification reactions within a disposable test device. The test device features a first reaction chamber containing a nucleic acid amplification reagent, such as primers and nucleotides, and a second reaction chamber that is either filled with or in fluid communication with a second nucleic acid amplification reagent, like an amplification enzyme. The instrument includes a support structure for the test device and a temperature control system that maintains the first reaction chamber at an elevated temperature while preserving the second reagent at a lower temperature. An actuator facilitates fluid communication between the two chambers after the reaction has occurred, and a pneumatic system aids in transferring the reaction solution.
Career Highlights
Throughout his career, Christopher Cotter has worked with various companies, including Biomerieux, Inc. His experience in the industry has allowed him to develop cutting-edge technologies that address critical needs in the field of diagnostics.
Collaborations
Cotter has collaborated with several professionals in his field, including Bryan W Kluttz and Geoff A McKinley. These collaborations have contributed to the advancement of his innovative projects and patents.
Conclusion
Christopher Cotter is a distinguished inventor whose work in nucleic acid amplification technology has made a significant impact on diagnostic testing. His innovative patents and collaborations reflect his commitment to advancing the field and improving healthcare solutions.